Last reviewed · How we verify
NCT05951374
Madany Triangle; a New Era of Laparoscopic Cholecystectomy
trial testing Madany triangle in Laparoscopic Cholecystectomy in 238 participants. Completed in 30 March 2023.
30 March 2023
Quick facts
| Lead sponsor | Aswan University Hospital |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 238 |
| Start date | 1 December 2019 |
| Primary completion | 30 March 2023 |
| Estimated completion | 30 March 2023 |
| Sites | 1 location across Egypt |
Drugs / interventions tested
- Madany triangle
Conditions studied
- Laparoscopic Cholecystectomy — all drugs for Laparoscopic Cholecystectomy →
- Cholecystitis; Gallstone — all drugs for Cholecystitis; Gallstone →
Sponsor
Aswan University Hospital
Who can join
Adults 8 to 80, any sex, with Laparoscopic Cholecystectomy or Cholecystitis; Gallstone. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Laparoscopic cholecystectomy has an increased incidence of extrahepatic biliary injury or bleeding. The common hepatic duct is on the medial border of the Calot triangle and at risk of injury. So, The investigators describe a new safety triangle with a more critical view of safety that is far from dangerous. Retrospectively, from December 2019 until March 2023, the investigators will review the medical records for patients who underwent laparoscopic cholecystectomy. The patients underwent cholecystectomy using a new technique in approaches to critical safety with recorded video and available follow up data were included. The patients who had intraoperatively extensive gallbladder adhesion that interfere with the dissection in this area, improper visualization of the cystic duct, patients whose did not operate by this new technique and patients whose have not video record of laparoscopic cholecystectomy will excluded from the study.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05951374
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Laparoscopic Cholecystectomy
Currently open trials in the same condition.
- NCT07440940 — Timing of Subcostal TAPB Combined With Rectus Sheath Block for Postoperative Pain After Laparoscopic Cholecystectomy · NA · recruiting
- NCT07488078 — Effect of Liberal and Restrictive IV Fluids on Recovery After Gallbladder Surgery · Phase 1 · recruiting
- NCT06632184 — Peritoneal Lavage Using Saline or Saline With Ondansetron for Pain Control After Laparoscopic Cholecystectomy · Phase 4 · active not recruiting
- NCT07445854 — Sensory Analysis and Cutaneous Mapping of Different Regional Anesthesia Techniques · recruiting
- NCT07186803 — AI and Safety in Laparoscopic Cholecystectomy: A Randomized Controlled Trial · Phase 3 · recruiting
Other Aswan University Hospital trials
Trials by the same sponsor.
- NCT06491394 — Lactoferrin Effect on Kidney and Heart of Rhabdomyolysis Rats · Phase 4 · completed
- NCT06211088 — Famotidine Versus Placebo in Emergency Pediatric Surgery As a Risk to Postoperative Nausea and Vomiting · NA · completed
- NCT06583590 — Evaluation of Efficacy of Botulinum Toxin A Plus Oral Tadalafil 5 mg in Diabetic Men With Erectile Dysfunction · Phase 2, PHASE3 · recruiting
- NCT06537323 — Femoral Nerve Block, Periarticular Nerve Group (PENG) Block, and Preoperative IV Fentanyl · NA · recruiting
- NCT06535256 — Compare Intraperitoneal Instillation of Bupivacaine+dexmedetomidine Versus Bupivacaine+dexamethasone on Postoperative Pa · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05951374 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Aswan University Hospital
- Last refreshed: 19 July 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05951374.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing